Clinical Trial of TN-401 Gene Therapy for the Potential Treatment of PKP2-Associated Arrhythmogenic Right Ventricular ...

Chief Executive Officer of Tenaya Therapeutics. "Funds from this grant will support our ongoing RIDGE-1 clinical trial of TN-401, a potential best-in-class gene therapy for the treatment of PKP2 ...

Amid these developments, Tenaya announced the departure of Leone Patterson, its Chief Financial and Business Officer, and is currently seeking a replacement. Despite this, analyst firms such as H ...

showing confidence in Tenaya's ongoing developments. However, the company has also announced the departure of Leone Patterson, its Chief Financial and Business Officer, and is currently seeking a ...

Hercules Capital brings a conservative yet flexible BDC strategy and a focus on innovative companies. Read why dividend ...

In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa, who has ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Analyst firms such as H.C. Wainwright and Piper Sandler have maintained their Buy and Overweight ratings respectively, showing confidence in Tenaya's ongoing developments. However, the company has ...